| scholarly article | Q13442814 |
| P2093 | author name string | Takashi Takeuchi | |
| Satoru Kyo | |||
| Yutaka Shimizu | |||
| Masaki Inoue | |||
| Tohru Kiyono | |||
| Kiyoshi Mizuguchi | |||
| Shizuka Mita | |||
| P2860 | cites work | Comparison in gene expression of secretory human endometrium using laser microdissection | Q24796585 |
| Dienogest | Q28289898 | ||
| Analysis of aromatase and 17beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection | Q28305759 | ||
| Identification of an invasive, N-cadherin-expressing epithelial cell type in endometriosis using a new cell culture model | Q28363408 | ||
| DNA microarray analysis of gene expression profiles in deep endometriosis using laser capture microdissection. | Q30766164 | ||
| Hormonal pathology of the endometrium | Q33886753 | ||
| Progestins and progesterone in hormone replacement therapy and the risk of breast cancer | Q34420425 | ||
| Endometriosis: aetiology, pathogenesis and treatment | Q34427750 | ||
| New progestagens for contraceptive use. | Q34468158 | ||
| New progestogens: a review of their effects in perimenopausal and postmenopausal women | Q34551983 | ||
| Current place of progestins in the treatment of endometriosis-related complaints | Q34847482 | ||
| Endometriosis: treatment strategies | Q35596254 | ||
| Successful immortalization of endometrial glandular cells with normal structural and functional characteristics | Q35843291 | ||
| Aromatase and other steroidogenic genes in endometriosis: translational aspects | Q36241031 | ||
| Advances in the management of endometriosis: an update for clinicians | Q36310331 | ||
| Progesterone resistance in endometriosis: link to failure to metabolize estradiol | Q36365708 | ||
| Inflammatory status influences aromatase and steroid receptor expression in endometriosis. | Q36509755 | ||
| The role of progestins in treating the pain of endometriosis | Q36650353 | ||
| Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial | Q39316616 | ||
| Clinical response of abnormal endometrial growth to hormonal treatment | Q40642662 | ||
| Regulation of functional steroid receptors and ligand-induced responses in telomerase-immortalized human endometrial epithelial cells | Q42476771 | ||
| The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro | Q43560500 | ||
| Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27(Kip1) association with cyclin E-Cdk2. | Q43759022 | ||
| Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study | Q43950321 | ||
| A novel organotypic culture model for normal human endometrium: regulation of epithelial cell proliferation by estradiol and medroxyprogesterone acetate | Q45234417 | ||
| Stromal progesterone receptors mediate the inhibitory effects of progesterone on estrogen-induced uterine epithelial cell deoxyribonucleic acid synthesis | Q46200500 | ||
| Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kappa B inactivation in endometriotic stromal cells | Q46468485 | ||
| Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin | Q46594488 | ||
| The activation function-1 domain of estrogen receptor alpha in uterine stromal cells is required for mouse but not human uterine epithelial response to estrogen. | Q46683753 | ||
| High-dose pilot study with the novel progestogen dienogestin patients with endometriosis | Q46979540 | ||
| Human 17beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression and localization in term placenta and in endometrium during the menstrual cycle. | Q50896417 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 693-701 | |
| P577 | publication date | 2009-06-05 | |
| P1433 | published in | Molecular Human Reproduction | Q15761794 |
| P1476 | title | Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression | |
| P478 | volume | 15 |
| Q42090449 | Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: A meta-analysis and systematic review |
| Q34343640 | Decorin induced by progesterone plays a crucial role in suppressing endometriosis |
| Q28296264 | Dienogest: a review of its use in the treatment of endometriosis |
| Q38663754 | Does dienogest influence the inflammatory response of endometriotic cells? A systematic review. |
| Q39258005 | Effects of dienogest on surgically induced endometriosis in rats after repeated oral administration |
| Q43061010 | Krüppel-like factor 4 mediates anti-proliferative effects of progesterone with G₀/G₁ arrest in human endometrial epithelial cells |
| Q35107985 | Lipoxin A₄ prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin E₂ production and estrogen signaling |
| Q48059956 | Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study |
| Q38471471 | Progestin effects in endometriosis treatment: new research on mechanisms |
| Q28083257 | Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer |
| Q52776100 | Short-term histopathological effects of dienogest therapy on ovarian endometriomas: in vivo, nonrandomized, controlled trial. |
| Q33778690 | The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis |
| Q37946399 | The role of prostaglandin E2 in endometriosis |
| Q50946182 | The use of an oral contraceptive containing estradiol valerate and dienogest before office operative hysteroscopy: a feasibility study. |
Search more.